To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
The expansion makes Exothera one of the largest viral vector facilities in Europe
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Hitz shall assume new role from January 17th, 2022
The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Subscribe To Our Newsletter & Stay Updated
